Variant · Snv
MAD2L2 NM_006341.4(MAD2L2):c.502-14T>G
CI-VAR-00276993Explore in graph →NM_006341.4:c.502-14T>GClinVar 1921850 rs878778
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1921850 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Hepatocellular carcinoma; Nonpapillary renal cell carcinoma; Ovarian cancer; Uterine carcinosarcoma; Acute myeloid leukemia; Uterine corpus endometrial carcinoma; Chronic lymphocytic leukemia/small lymphocytic lymphoma; Familial pancreatic carcinoma; Malignant lymphoma, large B-cell, diffuse; Sarcoma; Lymphoma; Cholangiocarcinoma | germline | 3 | Feb 04, 2026 | clinvar |